Note: This document contains side effect information about cyclopentolate ophthalmic. Some of the dosage forms listed on this page may not apply to the brand name Cyclogyl.
Applies to cyclopentolate ophthalmic: ophthalmic solution
Along with its needed effects, cyclopentolate ophthalmic (the active ingredient contained in Cyclogyl) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor as soon as possible if any of the following side effects occur while taking cyclopentolate ophthalmic:
Symptoms of too much medicine being absorbed into the body
Some side effects of cyclopentolate ophthalmic may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Applies to cyclopentolate ophthalmic: compounding powder, ophthalmic solution
Local irritation may occur following instillation and the frequency is dependent upon the concentration used.
Frequency not reported: Intraocular pressure increased, burning, photophobia, vision blurred, irritation, hyperemia, conjunctivitis, blepharoconjunctivitis, punctate keratitis, synechiae, redness of eyes, lacrimation, mucus discharge, allergic conjunctivitis, eye pruritus
Postmarketing reports: Mydriasis prolonged, eye irritation, eye pain
Frequency not reported: Ataxia, incoherent speech, hyperactivity, seizure, drowsiness, coma, medullary paralysis, convulsion, somnolence, incoordination, poor balance, tremor
Postmarketing reports: Retrograde amnesia, dizziness, headache
Frequency not reported: Secretion decreased in pharynx/bronchi/nasal passages
Frequency not reported: Tachycardia, vasodilation
Frequency not reported: Skin rash, flushing, dry skin
Postmarketing reports: Erythema
Frequency not reported: Abdominal distention infants, gastrointestinal motility diminished, salivary secretion decreased, sweat gland secretion decreased, necrotizing colitis, gastroenteritis, dry mouth
Postmarketing reports: Nausea, vomiting
Frequency not reported: Urinary retention
Frequency not reported: Restlessness, hallucination, disorientation, failure to recognize people
Postmarketing reports: Confusion, agitation
Postmarketing reports: Hypersensitivity
Frequency not reported: Feeding intolerance
Frequency not reported: Hyperpyrexia, death, vertigo
Postmarketing reports: Pyrexia, fatigue, gait disturbed
Medically reviewed by BestRx Medical Team Last updated on 1/1/2020.
Source: Drugs.com Cyclogyl